Pantoprazol Aurobindo (Pantoprazole)

Pantoprazol Aurobindo is a proton pump inhibitor that acts on the gastric acid secretion pathway. It is indicated for several acid‑related gastrointestinal conditions:

• Gastro‑oesophageal reflux disease (GERD): provides symptomatic relief and promotes healing of the oesophageal lining.
• Erosive oesophagitis: accelerates ulcer healing in the oesophagus.
• Zollinger‑Ellison syndrome: controls excessive gastric acid secretion associated with this rare endocrine disorder.

• Pantoprazole selectively and irreversibly binds to the H+/K+‑ATPase enzyme (the gastric proton pump) on the secretory surface of parietal cells. By inhibiting this final step of acid production, it markedly lowers both basal and stimulated gastric acidity, allowing mucosal healing and symptom control.

Pantoprazol Aurobindo may cause adverse reactions, most of which are mild and reversible.

Common Side Effects

• Headache: mild to moderate intensity.
• Diarrhoea: loose stools without blood.
• Nausea: feeling of stomach upset.
• Abdominal pain: cramp‑like discomfort.
• Flatulence: excess gas.
• Constipation: reduced bowel movements.

Serious or Rare Side Effects

• Severe allergic reaction: rash, itching, swelling, dizziness or trouble breathing.
• Clostridioides difficile infection: persistent watery diarrhoea.
• Low magnesium levels: muscle cramps, irregular heartbeat.
• Liver enzyme elevation: abnormal liver function tests.
• Fracture risk: reduced bone mineral density with long‑term use.

When prescribing Pantoprazol Aurobindo, clinicians should consider several safety aspects:

• Assess renal function: dose adjustment may be needed in severe impairment.
• Review concomitant medications: potential for altered absorption of drugs requiring acidic pH.
• Monitor long‑term use: evaluate need for continued therapy after several months.
• Pregnancy and lactation: use only if clearly needed after risk‑benefit assessment.
• Elderly patients: start with the lowest effective dose and monitor for fractures.
• Store below 25°C: keep in the original packaging, protect from moisture and direct sunlight.

Pantoprazol Aurobindo can affect the pharmacokinetics of several medicines. Awareness of the interaction potential helps optimise therapy.

Major Interactions (Avoid)

• Antifungal azoles (ketoconazole, itraconazole): reduced absorption due to increased gastric pH.
• HIV protease inhibitors (lopinavir/ritonavir): decreased plasma concentrations.
• Clopidogrel: diminished antiplatelet effect.

Moderate Interactions (Monitor Closely)

• Warfarin: possible increase in INR; monitor coagulation.
• Methotrexate: reduced renal clearance; check serum levels.
• Digoxin: slight increase in serum concentration; observe for toxicity.